We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01226953
Recruitment Status : Completed
First Posted : October 22, 2010
Last Update Posted : December 30, 2011
Information provided by (Responsible Party):
Novartis ( Novartis Vaccines )